1 / 5

Summary of Conclusions

Summary of Conclusions. Expert Meeting on a High-Level ACT Subsidy January 18-19, 2007. Main Agreements from Day 1. Vital and urgent need to increase access to ACTs to slow growing drug resistance and rising malaria deaths Broad support for a high-level buyer subsidy

ryanadan
Download Presentation

Summary of Conclusions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Summary of Conclusions Expert Meeting on a High-Level ACT Subsidy January 18-19, 2007

  2. Main Agreements from Day 1 • Vital andurgent need to increase access to ACTs to slow growing drug resistance and rising malaria deaths • Broad support for a high-level buyer subsidy • Confidence that the technical issues can be overcome • Agreement that the most appropriate partners will be engaged

  3. Many issues were raised yesterday • Additional health interventions • Actors and partners • Incentives for suppliers and distributors • End-product vs. component subsidy • National regulatory issues • Formal vs. informal sector • Tariffs and taxes • Big-bang vs. phased entry • End-user prices • Patient and provider behavior • Product selection and availability • Home-based management • Drug resistance • Data for monitoring • Eligibility of producers • Compliance • Sustainability • Accountability • Premium vs. non-premium • Effective promotion of generic drugs • Quality of drugs • Local needs • Predictability of demand • Conditionalities • Incentives for innovation • Market distortion • Demand forecasting • Local manufacturing • Equity

  4. Subsidy-Design Tasks Broader Systemic Issues Two types of issues • Estimate required funding commitment and define subsidy levels/ex-factory price • Outline facility architecture and management • Develop communication strategy to promote uptake of ACTs • Plan for the responsible introduction of ACTs (monitoring of resistance, appropriate technical support, operational research, monitoring and evaluation, equity considerations, sustainability concerns) • Strengthen policies to promote quality assurance, pre-qualification, compliance and local manufacturing • Strengthen integrated national malaria control programs • Leverage community based programs and bolster home based management initiatives • Refine demand forecasting • Rationalize relevant national policies (e.g. taxes and tariffs, OTC access)

  5. Proposed Timeline • A steering committee will be formed • Roll-Back Malaria will convene the first meeting of the steering committee • Key dates: • First draft of report prepared by Dalberg by early March • Detailed plan finalized by Dalberg by June • Launch meeting in about November (in Sub-Saharan Africa)

More Related